PL3755339T3 - 3-beta-(4-metoksybenzyloksy)pregn-5-en-20-on do stosowania w leczeniu zaburzeń związanych z kannabinoidami - Google Patents

3-beta-(4-metoksybenzyloksy)pregn-5-en-20-on do stosowania w leczeniu zaburzeń związanych z kannabinoidami

Info

Publication number
PL3755339T3
PL3755339T3 PL19705190.7T PL19705190T PL3755339T3 PL 3755339 T3 PL3755339 T3 PL 3755339T3 PL 19705190 T PL19705190 T PL 19705190T PL 3755339 T3 PL3755339 T3 PL 3755339T3
Authority
PL
Poland
Prior art keywords
pregn
methoxybenzyloxy
cannabinoids
beta
treatment
Prior art date
Application number
PL19705190.7T
Other languages
English (en)
Inventor
Pier Vincenzo PIAZZA
Sandy FABRE
Mathilde METNA
Stéphanie MONLEZUN
Arnau BUSQUET-GARCIA
Daniela COTA
Giovanni Marsicano
Jean-Michel REVEST
Monique VALLÉE
Original Assignee
Aelis Farma
INSERM (Institut National de la Santé et de la Recherche Médicale)
Universite de Bordeaux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aelis Farma, INSERM (Institut National de la Santé et de la Recherche Médicale), Universite de Bordeaux filed Critical Aelis Farma
Publication of PL3755339T3 publication Critical patent/PL3755339T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
PL19705190.7T 2018-02-20 2019-02-20 3-beta-(4-metoksybenzyloksy)pregn-5-en-20-on do stosowania w leczeniu zaburzeń związanych z kannabinoidami PL3755339T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18305177 2018-02-20
PCT/EP2019/054217 WO2019162328A1 (en) 2018-02-20 2019-02-20 3beta-(4-methoxybenzyloxy)pregn-5-en-20-one for use in the treatment of cannabinoids-related disorders

Publications (1)

Publication Number Publication Date
PL3755339T3 true PL3755339T3 (pl) 2024-04-22

Family

ID=61283142

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19705190.7T PL3755339T3 (pl) 2018-02-20 2019-02-20 3-beta-(4-metoksybenzyloksy)pregn-5-en-20-on do stosowania w leczeniu zaburzeń związanych z kannabinoidami

Country Status (24)

Country Link
US (2) US11484537B2 (pl)
EP (1) EP3755339B1 (pl)
JP (1) JP7254100B2 (pl)
KR (1) KR102695380B1 (pl)
CN (1) CN111757740B (pl)
AU (1) AU2019223049B2 (pl)
BR (1) BR112020017026A2 (pl)
CA (1) CA3090975C (pl)
CL (1) CL2020002147A1 (pl)
DK (1) DK3755339T3 (pl)
ES (1) ES2971103T3 (pl)
FI (1) FI3755339T3 (pl)
HR (1) HRP20240276T1 (pl)
HU (1) HUE065809T2 (pl)
IL (1) IL276697B2 (pl)
LT (1) LT3755339T (pl)
MA (1) MA51891B1 (pl)
MD (1) MD3755339T2 (pl)
MX (1) MX2020008687A (pl)
PL (1) PL3755339T3 (pl)
PT (1) PT3755339T (pl)
RS (1) RS65281B1 (pl)
SI (1) SI3755339T1 (pl)
WO (1) WO2019162328A1 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2537535A1 (en) * 2003-09-02 2005-03-10 Solvay Pharmaceuticals Gmbh Novel medical use of selective cb1-receptor antagonists
BR112013029673B1 (pt) 2011-05-20 2021-11-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonistas de receptor de cb1
EP3176176A1 (en) * 2012-11-28 2017-06-07 INSERM (Institut National de la Santé et de la Recherche Médicale) 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone

Also Published As

Publication number Publication date
ES2971103T3 (es) 2024-06-03
CN111757740A (zh) 2020-10-09
US20210030768A1 (en) 2021-02-04
HUE065809T2 (hu) 2024-06-28
EP3755339B1 (en) 2024-01-03
MA51891A (fr) 2021-05-26
AU2019223049A1 (en) 2020-08-13
KR20200122324A (ko) 2020-10-27
WO2019162328A1 (en) 2019-08-29
RS65281B1 (sr) 2024-03-29
MA51891B1 (fr) 2024-03-29
JP7254100B2 (ja) 2023-04-07
BR112020017026A2 (pt) 2020-12-15
MX2020008687A (es) 2020-09-25
CA3090975A1 (en) 2019-08-29
KR102695380B1 (ko) 2024-08-16
EP3755339A1 (en) 2020-12-30
RU2020130586A (ru) 2022-03-22
FI3755339T3 (fi) 2024-02-21
US11484537B2 (en) 2022-11-01
PT3755339T (pt) 2024-02-26
IL276697A (en) 2020-09-30
CL2020002147A1 (es) 2021-01-15
JP2021514009A (ja) 2021-06-03
SI3755339T1 (sl) 2024-05-31
CN111757740B (zh) 2023-12-15
MD3755339T2 (ro) 2024-06-30
US20230226076A1 (en) 2023-07-20
HRP20240276T1 (hr) 2024-05-10
CA3090975C (en) 2024-01-09
IL276697B1 (en) 2024-04-01
DK3755339T3 (da) 2024-02-26
AU2019223049B2 (en) 2024-07-04
IL276697B2 (en) 2024-08-01
LT3755339T (lt) 2024-03-25

Similar Documents

Publication Publication Date Title
IL289650A (en) Azolopyrimidine for the treatment of cancer-related disorders
IL271085A (en) Bacteria to treat disorders
IL277805A (en) Use of gaboksadol in the treatment of substance use disorders
IL275349A (en) Use of hM4Di in the treatment of seizure disorders
IL269894B (en) Small organic molecules for use in the treatment of neuroinflammatory diseases
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
IL274838A (en) Use of MIR101 or MIR128 in the treatment of seizure disorders
ZA201806894B (en) (+)-azasetron for use in the treatment of ear disorders
IL276697A (en) 3 Beta-(4-methoxybenzyloxy)paragan-5-en-20-one for use in the treatment of cannabinoid-related disorders
LT3897655T (lt) 3beta-(benziloksi)-17alfa-metil-pregn-5-en-20-onas, skirtas naudoti kognityvinių sutrikimų gydymui
PL3148990T3 (pl) Związki tiazolidynonu i ich zastosowanie w leczeniu zaburzeń psychiatrycznych neurologicznych i stanów zapalnych, w szczególności stanów zapalnych układu nerwowego
SG11202007642RA (en) Treatment of disorders with tasimelteon
PT3442537T (pt) (+)-azasetrom para utilização no tratamento de doenças do ouvido
SG11202100269VA (en) Compounds for use in the treatment of fascioliasis
GB201820455D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820452D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820451D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
HUE065063T2 (hu) Brómhexin a fájdalom kezelésére
PT3148990T (pt) Compostos de tiazolidinona e seu uso no tratamento de condições psiquiátricas ou distúrbios neurológicos e inflamação, particularmente neuroinflamação